ABOUT ELITE
Overview
Our Facility
Management & Key Employees
Our Board
Careers
PRODUCTS
PIPELINE
Generic
Branded
TECHNOLOGY
Technology Overview
How It Works
One Bead System
Two Bead System
INVESTOR RELATIONS
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
HOME
|
CAREERS
|
CONTACT
|
NEWS
|
Skip to content
About Elite
Overview
Management & Key Employees
Our Board
Careers
Products
Pipeline
Generic
Branded
Technology
Technology Overview
How It Works
One Bead System
Two Bead System
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Shareholder Meeting
Governance Documents
Investor Contacts
Email Alerts
Investor Relations
Press Releases
Events &Presentations
SEC Filings
ShareholderMeeting
GovernanceDocuments
Investor Contacts
Email Alerts
Press Releases
Select:
Show All
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
Archived
Dec 20, 2005
Elite Announces Amendment to Agreement with IntelliPharmaCeutics
Dec 08, 2005
Elite Announces Successful Results On Abuse Resistant Technology For Narcotic Analgesics
Dec 07, 2005
ELITE PHARMACEUTICALS TO PRESENT AT THE NEW YORK SOCIETY OF SECURITY ANALYSTS 8TH ANNUAL HEALTHCARE INDUSTRY CONFERENCE
Nov 15, 2005
ELITE PHARMACEUTICALS REVIEWS BUSINESS DEVELOPMENTS AND PROJECTED CORPORATE MILESTONES
Nov 09, 2005
Elite Pharmaceuticals, Inc. (AMEX: ELI) will hold a telephone conference call
Sep 07, 2005
ELITE PHARMACEUTICAL ANNOUNCES SUCCESSFUL COMPLETION OF BOND REFINANCING
Jul 27, 2005
ELITE PHARMACEUTICALS TO PRESENT AT THE BANC OF AMERICA SECURITIES 2005 SPECIALTY PHARMACEUTICS CONFERENCE
Jun 28, 2005
Elite Pharmaceuticals Announces Agreement for the Development of a Controlled Release Product
Jun 22, 2005
Elite Pharmaceuticals and IntelliPharmaCeutics Announce Agreement for the Development of a Controlled Release Product
May 26, 2005
FDA Approves IND for Elite Pharmaceuticals Abuse-Resistant Oxycodone Product
21
22
23
24
25
26
27
28
29
<<
<
>
>>
Back to top
Privacy
